About 605,000 sf of laboratory space was absorbed by the state's biotech industry in the six-month period ended Sept. 30, with Cambridge the clear winner in the boom. Cambridge absorbed 531,000 sf of the space during the period, an absorption that was the greatest for any two quarter period in the history of the city's lab market, the report found.
In Boston's 2.5-million-sf lab market, the city experienced 34,000 sf of negative absorption during the last six months, increasing the city's vacancy rate to 4.1% from 2.7%. Space constraints is a factor in the increase in vacancy. The region's suburban market saw 108,000 sf of positive absorption during the period which lowered suburban laboratory vacancy from 23.8 % to 20.9%.
Among the region's largest lab space users was Novartis, which became the largest lab user in Cambridge with the addition of 66,000 sf at Technology Square.
The report also found that more than 1.5 million sf of new biotech space will come on line in Boston and its suburbs within the next two years.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
